OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Virology is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Editorial Board	179
Hepatitis-B virus: replication cycle, targets, and antiviral approaches	140
Inhaled aerosol viral-vectored vaccines against tuberculosis	116
Mutational escape from cellular immunity in viral hepatitis: variations on a theme	82
Transmission patterns of hepatitis E virus	81
Colonization of peripheral ganglia by herpes simplex virus type 1 and 2	78
The enigmatic roles of Anelloviridae and Redondoviridae in humans	73
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy	65
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?	65
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19	63
Future considerations for the mRNA-lipid nanoparticle vaccine platform	63
Structural basis for neutralization of enterovirus	62
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs	60
Editorial Board	58
Virus–host protein interactions as footprints of human cytomegalovirus replication	53
Editorial overview: Viral pathogenesis	52
Human placental models for studying viral infections	48
Editorial overview: Mechanisms in the molecular interactions of plants with viruses and viroids	47
Recent progress in development of monoclonal antibodies against human cytomegalovirus	46
Editorial Board	44
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity	43
Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2	42
Hepatitis C virus envelope protein dynamics and the link to hypervariable region 1	42
New preventive strategies for respiratory syncytial virus infection in children	42
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation	40

The journey of herpesvirus capsids and genomes to the host cell nucleus	38
Emerging technologies in the study of the virome	37
Adenovirus – a blueprint for gene delivery	36
Shopping for phages? Unpacking design rules for therapeutic phage cocktails	35
Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection	34
A review of broadly protective monoclonal antibodies to treat Ebola virus disease	34
A complex immune communication between eicosanoids and pulmonary macrophages	33
Perspective on taxonomic classification of uncultivated viruses	33
Epigenetic control of the Epstein-Barr lifecycle	33
Platelets in the pathogenesis of flavivirus disease	32
Mitigation of evolved bacterial resistance to phage therapy	30
The enigma of picobirnaviruses: viruses of animals, fungi, or bacteria?	30
Engineering therapeutic phages for enhanced antibacterial efficacy	29
Retasking of canonical antiviral factors into proviral effectors	28
Editorial Board	28
Asymmetry in icosahedral viruses	27
When good turns bad: how viruses exploit innate immunity factors	26
Tissue-resident memory T cells in protective immunity to influenza virus	26
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity	26
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities	25
Mechanisms of HCV resistance to broadly neutralizing antibodies	24
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?	24
Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity	24
Modeling zoonotic and vector-borne viruses	24
Hemagglutinin stability as a key determinant of influenza A virus transmission via air	24
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications	23
Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets	23
Immune responses to human respiratory coronaviruses infection in mouse models	23
The virome of vector mosquitoes	23
Oncogenic Animal Herpesviruses	23
Role of the viral polymerase during adaptation of influenza A viruses to new hosts	22
Diagnosis and monitoring of virus-associated cancer using cell-free DNA	22
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy	22
Antigenic evolution of SARS coronavirus 2	21
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases	21
The impact of high-resolution structural data on stemming the COVID-19 pandemic	21
Deimmunization of flagellin adjuvant for clinical application	21
The biology of papillomavirus PDZ associations: what do they offer papillomaviruses?	20
Bat virome research: the past, the present and the future	20
Editorial overview	20
Viral Z-RNA triggers ZBP1-dependent cell death	20
Advances in human monoclonal antibody therapy for HBV infection	20